TY - JOUR
T1 - External validation of a deep learning electrocardiogram algorithm to detect ventricular dysfunction
AU - Attia, Itzhak Zachi
AU - Tseng, Andrew S.
AU - Benavente, Ernest Diez
AU - Medina-Inojosa, Jose R.
AU - Clark, Taane G.
AU - Malyutina, Sofia
AU - Kapa, Suraj
AU - Schirmer, Henrik
AU - Kudryavtsev, Alexander V.
AU - Noseworthy, Peter A.
AU - Carter, Rickey E.
AU - Ryabikov, Andrew
AU - Perel, Pablo
AU - Friedman, Paul A.
AU - Leon, David A.
AU - Lopez-Jimenez, Francisco
N1 - Funding Information:
The Know Your Heart study is a component of the International Project on Cardiovascular Disease in Russia (IPCDR). IPCDR was funded by a Wellcome Trust Strategic Award (100217), supported by funds from the Norwegian Ministry of Health and Care Services , Norwegian Institute of Public Health, and UiT The Arctic University of Norway . The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DAL’s contribution was partly undertaken within the framework of the HSE University Basic Research Program.
Publisher Copyright:
© 2020
PY - 2021/4/15
Y1 - 2021/4/15
N2 - Objective: To validate a novel artificial-intelligence electrocardiogram algorithm (AI-ECG) to detect left ventricular systolic dysfunction (LVSD) in an external population. Background: LVSD, even when asymptomatic, confers increased morbidity and mortality. We recently derived AI-ECG to detect LVSD using ECGs based on a large sample of patients treated at the Mayo Clinic. Methods: We performed an external validation study with subjects from the Know Your Heart Study, a cross-sectional study of adults aged 35–69 years residing in two cities in Russia, who had undergone both ECG and transthoracic echocardiography. LVSD was defined as left ventricular ejection fraction ≤ 35%. We assessed the performance of the AI-ECG to identify LVSD in this distinct patient population. Results: Among 4277 subjects in this external population-based validation study, 0.6% had LVSD (compared to 7.8% of the original clinical derivation study). The overall performance of the AI-ECG to detect LVSD was robust with an area under the receiver operating curve of 0.82. When using the LVSD probability cut-off of 0.256 from the original derivation study, the sensitivity, specificity, and accuracy in this population were 26.9%, 97.4%, 97.0%, respectively. Other probability cut-offs were analysed for different sensitivity values. Conclusions: The AI-ECG detected LVSD with robust test performance in a population that was very different from that used to develop the algorithm. Population-specific cut-offs may be necessary for clinical implementation. Differences in population characteristics, ECG and echocardiographic data quality may affect test performance.
AB - Objective: To validate a novel artificial-intelligence electrocardiogram algorithm (AI-ECG) to detect left ventricular systolic dysfunction (LVSD) in an external population. Background: LVSD, even when asymptomatic, confers increased morbidity and mortality. We recently derived AI-ECG to detect LVSD using ECGs based on a large sample of patients treated at the Mayo Clinic. Methods: We performed an external validation study with subjects from the Know Your Heart Study, a cross-sectional study of adults aged 35–69 years residing in two cities in Russia, who had undergone both ECG and transthoracic echocardiography. LVSD was defined as left ventricular ejection fraction ≤ 35%. We assessed the performance of the AI-ECG to identify LVSD in this distinct patient population. Results: Among 4277 subjects in this external population-based validation study, 0.6% had LVSD (compared to 7.8% of the original clinical derivation study). The overall performance of the AI-ECG to detect LVSD was robust with an area under the receiver operating curve of 0.82. When using the LVSD probability cut-off of 0.256 from the original derivation study, the sensitivity, specificity, and accuracy in this population were 26.9%, 97.4%, 97.0%, respectively. Other probability cut-offs were analysed for different sensitivity values. Conclusions: The AI-ECG detected LVSD with robust test performance in a population that was very different from that used to develop the algorithm. Population-specific cut-offs may be necessary for clinical implementation. Differences in population characteristics, ECG and echocardiographic data quality may affect test performance.
KW - Artificial intelligence
KW - Electrocardiogram
KW - Left ventricular systolic dysfunction
KW - Machine learning
UR - http://www.scopus.com/inward/record.url?scp=85100660726&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85100660726&partnerID=8YFLogxK
U2 - 10.1016/j.ijcard.2020.12.065
DO - 10.1016/j.ijcard.2020.12.065
M3 - Article
C2 - 33400971
AN - SCOPUS:85100660726
SN - 0167-5273
VL - 329
SP - 130
EP - 135
JO - International Journal of Cardiology
JF - International Journal of Cardiology
ER -